Brief: Eql Pharma Q1 EBIT Loss SEK 13.7 Mln
07/08/2026 06:02
BRIEF-Eql Pharma Q1 EBIT Loss SEK 13.7 Mln Aug 7 (Reuters) - EQL Pharma AB EQL.ST:
Q1 SALES SEK 106.9M; ADJUSTED GROSS MARGIN 35%; ADJUSTED EBITDA MARGIN 12%
Q1 OPERATING PROFIT (EBIT) SEK -13.7M
FORECASTS FY2026/27 SALES GROWTH AROUND 15%; LONG-TERM TARGET 30% UNCHANGED
Source text: ID:nWkr4tMvwL
Further company coverage: EQL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))